The Riverside closure underscores a hard truth: resilience is not free. Maintaining onshore or near-shore manufacturing ...

NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active ...

With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...

NORTH CHICAGO, Ill., Sept. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago ...

Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...

SAN DIEGO--(BUSINESS WIRE)--National Resilience, Inc., a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, proudly announces that its subsidiary, ...

ST. LOUIS--(BUSINESS WIRE)--The API Innovation Center (APIIC) today announced that it has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for ...

Pharmaceutical company AbbVie announced Tuesday that it will construct a new $195 million facility near its headquarters in North Chicago. AbbVie is one of the largest biomedical companies in the ...

Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...

Pharmaceutical Intermediates Market OverviewThe global pharmaceutical intermediates market is witnessing steady expansion as pharmaceutical manufacturing scales worldwide. Valued at approximately USD ...

While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily toward branded drugmakers, generic medicines and the companies that ...